Posts Tagged: Vito Imbasciani


CIRM considers hold on grants amid deluge of applications

CIRM chair Vito Imbasciani at the January CIRM board meeting, which was both online and in-person. California Stem Cell Report photo

California’s $12 billion stem cell agency is under “’unprecedented strain” and is ready to impose a five-month hold on applications for the key, $15 million research awards that support the final steps in bringing revolutionary treatments to patients.


CA stem cell agency gets interim chief

CIRM Board Chairman Vito Imbasciani, with interim president Jonathan Thomas, photo courtesy of CIRM

The former chairman of the California stem cell agency is back on the job with the $12 billion agency – this time as its interim president while a search proceeds for a permanent chief executive officer.


Amidst morale ‘crisis,’ CA stem cell agency could take months to find new president

The Sue and Bill Gross Stem Cell Research building at University of California Irvine, a CIRM major facility. Photo courtesy of CIRM

California’s $12 billion stem cell and gene therapy program could be treading water for the next 12 months in the view of at least one of its leaders as it searches for a new president of the 19-year-old enterprise. Past presidential searches have been burdened by a legal, dual executive arrangement that has been described by a former board member as a “dog’s breakfast.”


Stem cell agency chooses new board chair amidst funding uncertainty

Come March 28, Vito Imbascani is scheduled to be sworn in as the new chairman of the $12 billion California stem cell agency – an 18-year-old state program to develop revolutionary treatments for such things as brain and blood cancers, heart disease, diabetes, sickle cell disease, spina bifida, incontinence, blindness, arthritis, HIV, stroke, epilepsy and much more.

Support for Capitol Weekly is Provided by: